Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axis Biotec Group is a leading Brazilian biotechnology holding company that manages a portfolio of innovative life science businesses. The group's core operations include Cryopraxis, the largest stem cell bank in Brazil, and CellPraxis, a research-driven entity focused on regenerative medicine and advanced cell therapies. Through its subsidiary Silvestre Labs, the group also engages in the development and manufacturing of pharmaceutical products and active ingredients. Axis Biotec plays a pivotal role in the Brazilian biotech sector by bridging the gap between academic research and commercial healthcare applications. The company focuses on high-growth areas such as personalized medicine and biotechnology-derived therapeutics. Its strategic location in Rio de Janeiro allows it to leverage local scientific talent and infrastructure to drive innovation in the South American market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axis Biotec Group.